Senior insider sale
Chief Executive Officer at UNITY BIOTECHNOLOGY, INC. — senior position signals high conviction
$15.6K
5.24K shares
What this filing means
GHOSH ANIRVAN plans to sell 5.24K shares of UNITY BIOTECHNOLOGY, INC. valued at approximately $15.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/15/2023ACC: 0000950170-23-048371
DirectorOfficer· Chief Executive Officer
Since Mar 2020
5.24K
Shares to sell
$15.6K
Approx. market value
1.25K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units granted in 2022 under the Issuer's 2018 Incentive Award Plan
N/A
9/13/2023
1.25KTotal acquired1.25K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/13/2023 | Restricted Stock Units granted in 2022 under the Issuer's 2018 Incentive Award Plan N/A | 1.25K | — |
| Total | 1.25K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
581.00
Market value
$1.7K
8/2/2023
—Completed
Units to sell
1.02K
Market value
$2.9K
7/31/2023
—Completed
Units to sell
1.18K
Market value
$3.8K
6/26/2023
—Completed
Units to sell
1.21K
Market value
$4.1K
6/14/2023
Planned — Approximate Date
NASDAQPlanned
Units to sell
1.25K
Market value
$3.1K
9/14/2023
Total
Units
5.24K
Value
$15.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/2/2023 | 581.00 | $1.7K | — | Completed |
7/31/2023 | 1.02K | $2.9K | — | Completed |
6/26/2023 | 1.18K | $3.8K | — | Completed |
6/14/2023 | 1.21K | $4.1K | — | Completed |
| Planned — Approximate Date | ||||
9/14/2023 | 1.25K | $3.1K | NASDAQ | Planned |
| Total | 5.24K | $15.6K | ||